Citi has initiated coverage of EyePoint Pharmaceuticals (NASDAQ:EYPT) with a buy rating, stating it sees the company's drug ...

This story was excerpted from Anthony DiComo’s Mets Beat newsletter, written this week by Bill Ladson. To read the full newsletter, click here. And subscribe to get it regularly in your inbox.

Citigroup Inc. (NYSE:C) will release its fourth-quarter financial results before the opening bell on Wednesday, Jan. 15. Analysts expect the New York-based company to report quarterly earnings at ...

From Goldman Sachs to Morgan Stanley, the largest banks in the U.S. announced departures from an international climate group ...

Citi Bike is starting 2025 with another price increase, marking the fourth consecutive year the bike-share service has raised ...

Citi analysts shared a list of their “most preferred stocks” for 2025. These are “buy” rated stocks they believe investors ...

After Kotb departs her longtime role as co-host of 'Today' this week, Bush Hager will be joined by various celebrities.

The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...

Cybersecurity startups to watch in 2025 include recently funded companies with products for security operations, email ...

Triple Flag Precious Metals Corp. (TFPM) receives a Buy rating due to the well-mitigated risk of a globally diversified ...

Wright’s career was also marked by numerous memorable moments. He hit the first home run by a Mets player at Citi Field on ...

BofA analyst Ebrahim Poonawala raised the firm’s price target on Citi (C) to $95 from $90 and keeps a Buy rating on the shares. Despite a 33% ...